Madrid, 18 April, 2017
Liver progenitor cells participate in liver tumour heterogeneity and generally lead to benign tumour formation but sometimes they can also lead to more aggressive cancers
Cross-talk between malignant hepatocytes and neighbouring progenitor cells signals progenitor cells to become activated, to expand and to maintain them in an undifferentiated state
The malignant transformation of hepatocytes is the origin of most hepatocellular carcinomas, an aggressive type of liver cancer with high mortality rates. But these cells do not act alone. Research conducted by scientists at the Spanish National Cancer Research Centre (CNIO) reveals how hepatocytes "recruit" and "instruct" liver progenitor cells to contribute to the hepatic lesions.
"The cellular origin of liver cancer, as well as the origin of tumour heterogeneity, are not clear yet and may be context-dependent,” say the authors in the journal Cell Reports. Hepatocytes –the main liver cells– have been considered the main source of hepatocellular carcinomas but the results of this research provide various novel perspectives.
Liver section with a Sox9 staining showing the expansion of the hepatic progenitor cells, the so called the "ductular reaction" at the early stages of tumorigenesis and after expression of oncogenic URI specifically in hepatocytes. / CNIO
“What we are showing here is that hepatic progenitor cells expand during tumorigenesis and, at one point, they become transformed because of oncogenic hepatocyte cross-talk; this makes them participate in liver tumour development in general, and in hepatocellular carcinomas in particular,” explains Nabil Djouder, head of the Growth Factors, Nutrients and Cancer Group at the CNIO and main author of the paper.
Thanks to an animal model –generated by Djouder and his team– that fairly reproduces the tumour formation process seen in human hepatocarcinogenesis, and to other genetic experiments, the authors have tried to follow the formation of the lesions and to define the histopathology of the various tumours that develop in this organ, whether benign (regenerative nodules, adenomas) or malignant (hepatocellular carcinoma or HCC).
“This is what we’ve seen: oncogenic hepatocytes lead to hepatocellular carcinoma but, in a model that mimics human hepatocarcinogenesis, progenitor cells also participate in liver tumour heterogeneity. They mostly lead to benign tumours but sometimes they can lead to aggressive carcinomas”, points out Djouder. In other words, progenitor cells become oncogenic even though they were not initially transformed.
Malignant hepatocytes crosstalk and instruct neighbouring progenitor cells to become activated, maintaining them in an undifferentiated state while at the same time proliferating, becoming oncogenic themselves, and contributing to the lesions. This activation occurs, as shown by this study, when the hepatocytes secrete two substances (alpha-ketoglutarate and galectin-3) that act and transform progenitor cells.
“Blocking galectin-3 can block the cross-talk between these cells thereby reducing tumourigenesis”, a finding that could have therapeutic implications, explains Djouder.
This work was supported by the Spanish Ministry of Economy, Industry and Competitiveness (grant SAF2013-46089-R) and Worldwide Cancer Research –formerly AICR– (grant 11-0242).
Hepatocellular Carcinomas Originate Predominantly from Hepatocytes and Benign Lesions from Hepatic Progenitor Cells. Krishna S. Tummala, Marta Brandt, Ana Teijeiro, Osvaldo Graña, Robert F. Schwabe, Cristian Perna and Nabil Djouder (Cell Reports 2017). DOI: 10.